EWIT urges shareholders to reject Boaz Weinstein’s board shake-up plan

EWIT urges shareholders to reject Boaz Weinstein’s board shake-up plan

Edinburgh Worldwide Investment Trust, a Baillie Gifford-run technology-focused fund, is calling on shareholders to throw out a plan by Boaz Weinstein’s activist investment fund Saba Capital to overhaul its board of directors. The EWIT board said on Wednesday it would “strongly urge” shareholders to reject a plan by the U.S. hedge fund — which holds…

Read More
This biotech name is evolving into a major obesity play. How to trade it with options

This biotech name is evolving into a major obesity play. How to trade it with options

Amgen is entering a pivotal period the as it moves beyond its Enbrel franchise and repositions around obesity, rare disease and next-generation oncology. While Enbrel has entered a period of decline due to Medicare pricing reform, management has demonstrated credible execution in replacing that cash flow with a higher-quality pipeline. Early success from the Imdelltra…

Read More